9th Annual Biomarkers Congress

Genomics: Food and Drug Administration

Total Score People Score Events Score
14 12 12
Date Event Presentation Speakers
May 22, 2014 Drug Discovery Summit Drug Discovery Summit Richard Beger
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Genomics of Antibody Responses to Vaccination Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Hana Golding
Workshop 2: Immunity to Vaccines Hana Golding
May 31, 2013 ASCO Annual Meeting 2013 Career Choices: Options in Academia, Practice, Industry, and Government Richard Pazdur
May 28, 2013 NGS Translate Ensuring the Generation of High Quality NGS Data Weida Tong
April 6, 2013 AACR Annual Meetings Personalized Medicine in Clinical Trials: What You Need to Know Now Elizabeth Mansfield, U.S. Food and Drug Administration, Rockville, MD Elizabeth Mansfield
February 20, 2012 International Conference and Exhibition on Metabolomics & Systems Biology Track 1-5: Metabolomics and Toxicology Laura K. Schnackenberg
April 11, 2011 Personalized Medicine Partnerships Conference Companion Diagnostics | FDA's Current Thinking Elizabeth Mansfield
August 18, 2010 Challenges in Pre-Clinical & Clinical Development - Top 5 Challenges in Vaccines & Immunotherapeutics Perspectives on the Changing Regulatory Paradigm Elaine Esber
May 4, 2010 Biomarker World Congress 2010 Biomarkers and the Development of Personalized Medicine: A Regulatory Perspective Francis Kalush
Role of Biomarkers in Drug Development: Application in Late Phase Clinical Trials Yaning Wang
August 11, 2009 Inaugural Molecular Diagnostics for Infectious Disease Ensuring the Safety and Validity of Molecular Diagnostic Tests Alberto Gutierrez
November 12, 2008 Third Annual Post-Approval Drug Safety Strategies: Best Practices to Mitigate Risks throughout the Product's Life Cycle Chairperson’s Opening Remarks Federico Goodsaid
Translational Safety Biomarkers and the Path to Phase-1 Studies Federico Goodsaid
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Laura K. Schnackenberg
Eight Annual Metabolic Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: NMR Metabolomics: Characterization of Multi-Age Rodent Pediatric Models of Toxicity (14:00-14:30) Laura K. Schnackenberg
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY (13:30-15:00) Laura K. Schnackenberg
Third Annual Toxicity Biomarkers; METABOLITE BIOMARKERS OF TOXICITY: Characterization of Multi-Age Rodent Pediatric Models of Toxicity (14:00-14:30) Laura K. Schnackenberg
Pre-Conference Workshops; Biomarker Assay Development and Validation: Part II FDA Perspective on Development and Qualification of Biomarkers (13:00-13:30) Reena Philip
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.